Aspire Biopharma Holdings, Inc. — 10-Q Filings
12 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Aspire Biopharma Holdings, Inc. (ASBPW), sorted by most recent first. Each row links to the full filing on EdgarLookup. Aspire Biopharma Holdings, Inc. has filed 12 10-Q documents with the SEC since 2021. To view all SEC filings by Aspire Biopharma Holdings, Inc., see the full filings list.
All
10-K
10-Q
10-Q/A
25-NSE
3
4
4/A
424B3
424B4
425
8-A12B
8-K
8-K/A
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-K
NT 10-Q
PRE 14A
RW
S-1
S-1/A
S-4
S-4/A
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001493152-25-022595 | Nov 14, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0001641172-25-023573 | Aug 13, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0001641172-25-010316 | May 14, 2025 | Mar 31, 2025 |
| 10-Q | — | 0001493152-24-045850 | Nov 14, 2024 | Sep 30, 2024 |
| 10-Q | — | 0001493152-24-032815 | Aug 16, 2024 | Jun 30, 2024 |
| 10-Q | — | 0001493152-24-022728 | Jun 5, 2024 | Mar 31, 2024 |
| 10-Q | — | 0001493152-23-039795 | Nov 8, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0001410578-23-001594 | Aug 8, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0001410578-23-001031 | May 11, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0001410578-22-003172 | Nov 10, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0001410578-22-002287 | Aug 11, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0001410578-22-001691 | May 16, 2022 | Mar 31, 2022 |